A detailed history of Boston Trust Walden Corp transactions in Medtronic PLC stock. As of the latest transaction made, Boston Trust Walden Corp holds 137,214 shares of MDT stock, worth $11.1 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
137,214
Previous 138,660 1.04%
Holding current value
$11.1 Million
Previous $10.9 Million 13.2%
% of portfolio
0.09%
Previous 0.08%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$76.84 - $91.03 $111,110 - $131,629
-1,446 Reduced 1.04%
137,214 $12.4 Million
Q2 2024

Jul 19, 2024

SELL
$78.71 - $87.02 $291,620 - $322,409
-3,705 Reduced 2.6%
138,660 $10.9 Million
Q1 2024

Apr 22, 2024

SELL
$82.84 - $88.09 $1.28 Million - $1.36 Million
-15,475 Reduced 9.8%
142,365 $12.4 Million
Q4 2023

Jan 24, 2024

SELL
$69.43 - $83.43 $4.76 Million - $5.72 Million
-68,592 Reduced 30.29%
157,840 $13 Million
Q3 2023

Oct 18, 2023

SELL
$78.22 - $90.4 $878,410 - $1.02 Million
-11,230 Reduced 4.73%
226,432 $17.7 Million
Q2 2023

Jul 24, 2023

SELL
$79.47 - $91.38 $545,799 - $627,597
-6,868 Reduced 2.81%
237,662 $20.9 Million
Q1 2023

Apr 19, 2023

SELL
$76.72 - $87.58 $2.7 Million - $3.09 Million
-35,243 Reduced 12.6%
244,530 $19.7 Million
Q4 2022

Jan 20, 2023

BUY
$76.18 - $87.74 $1.73 Million - $1.99 Million
22,696 Added 8.83%
279,773 $0
Q3 2022

Oct 19, 2022

SELL
$80.75 - $95.31 $29.3 Million - $34.6 Million
-362,740 Reduced 58.52%
257,077 $20.8 Million
Q2 2022

Jul 22, 2022

BUY
$87.4 - $113.09 $166,584 - $215,549
1,906 Added 0.31%
619,817 $55.6 Million
Q1 2022

Apr 20, 2022

BUY
$100.58 - $112.38 $2.05 Million - $2.29 Million
20,377 Added 3.41%
617,911 $68.6 Million
Q4 2021

Jan 21, 2022

BUY
$99.53 - $127.75 $1.96 Million - $2.51 Million
19,645 Added 3.4%
597,534 $61.8 Million
Q3 2021

Oct 25, 2021

SELL
$122.75 - $135.17 $568,823 - $626,377
-4,634 Reduced 0.8%
577,889 $72.4 Million
Q2 2021

Jul 22, 2021

BUY
$118.19 - $131.5 $2.63 Million - $2.92 Million
22,226 Added 3.97%
582,523 $72.3 Million
Q1 2021

Apr 21, 2021

SELL
$111.18 - $119.74 $4.85 Million - $5.23 Million
-43,637 Reduced 7.23%
560,297 $66.2 Million
Q4 2020

Jan 15, 2021

BUY
$100.57 - $117.14 $783,239 - $912,286
7,788 Added 1.31%
603,934 $70.7 Million
Q3 2020

Oct 14, 2020

BUY
$90.13 - $108.78 $667,232 - $805,298
7,403 Added 1.26%
596,146 $62 Million
Q2 2020

Jul 23, 2020

BUY
$84.11 - $103.33 $2.03 Million - $2.49 Million
24,140 Added 4.28%
588,743 $54 Million
Q1 2020

Apr 21, 2020

BUY
$72.92 - $121.3 $3.61 Million - $6 Million
49,444 Added 9.6%
564,603 $50.9 Million
Q4 2019

Jan 10, 2020

BUY
$104.49 - $114.54 $716,278 - $785,171
6,855 Added 1.35%
515,159 $58.4 Million
Q3 2019

Oct 21, 2019

BUY
$98.02 - $111.18 $4.88 Million - $5.54 Million
49,804 Added 10.86%
508,304 $55.2 Million
Q2 2019

Jul 25, 2019

BUY
$84.15 - $99.38 $534,184 - $630,864
6,348 Added 1.4%
458,500 $44.7 Million
Q1 2019

Apr 16, 2019

BUY
$82.45 - $93.79 $903,487 - $1.03 Million
10,958 Added 2.48%
452,152 $41.2 Million
Q4 2018

Jan 17, 2019

SELL
$85.8 - $99.49 $235,521 - $273,100
-2,745 Reduced 0.62%
441,194 $40.1 Million
Q3 2018

Oct 23, 2018

SELL
$85.91 - $99.17 $387,883 - $447,752
-4,515 Reduced 1.01%
443,939 $43.7 Million
Q2 2018

Jul 25, 2018

SELL
$77.48 - $87.83 $540,035 - $612,175
-6,970 Reduced 1.53%
448,454 $38.4 Million
Q1 2018

Apr 13, 2018

SELL
$76.55 - $87.26 $2.27 Million - $2.59 Million
-29,655 Reduced 6.11%
455,424 $36.5 Million
Q4 2017

Jan 29, 2018

SELL
$76.93 - $83.5 $2.19 Million - $2.38 Million
-28,467 Reduced 5.54%
485,079 $39.2 Million
Q3 2017

Oct 13, 2017

BUY
$77.71 - $84.6 $39.9 Million - $43.4 Million
513,546
513,546 $39.9 Million

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $108B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Boston Trust Walden Corp Portfolio

Follow Boston Trust Walden Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Trust Walden Corp, based on Form 13F filings with the SEC.

News

Stay updated on Boston Trust Walden Corp with notifications on news.